SGLT-2 inhibitors were not linked to severe or nonsevere UTIs vs DPP-4 inhibitors or GLP-1 agonists.

Davidson MB. SGLT-2 inhibitors were not linked to severe or nonsevere UTIs vs DPP-4 inhibitors or GLP-1 agonists. Ann Intern Med. 2019 12 17; 171(12):JC70.

View in: PubMed

subject areas

Cohort Studies
Diabetes Mellitus, Type 2
Dipeptidyl-Peptidase IV Inhibitors
Glucagon-Like Peptide 1
Humans
Hypoglycemic Agents
Urinary Tract Infections

authors with profiles

Mayer B. Davidson, MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support